Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM2: SARS-CoV-2 Antibody Response and the Role of Serology in COVID-19 Diagnosis and Epidemiology

In this presentation, Professor Sharon Lewin discusses the kinetics of the antibody response following SARS-CoV-2 infection, current tests for antibody detection, and the use of serology assays in COVID-19 diagnosis and epidemiological studies
Sharon R. Lewin, AO, FRACP, FAHMS
Released: May 28, 2020

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
Faculty Medicine Dentistry and Health Sciences
University of Melbourne and Royal Melbourne Hospital
Consultant Infectious Diseases Physician
Department of Infectious Diseases
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Sharon R. Lewin, AO, FRACP, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: October 26, 2020

Dr. Jens Lundgren discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19 from CCO

Jens D. Lundgren, MD, DMSc Released: October 16, 2020

John Pagel, MD, PhD discusses incorporating telemedicine and other strategies into the care plan for patients with CLL during COVID-19

John Pagel Headshot John Pagel, MD, PhD Released: July 13, 2020

Living slideset on optimal management of CLL during the COVID-19 pandemic will be continually up-to-date as the situation evolves and new data emerge

Jacqueline Barrientos, MD, MS Nicole Lamanna, MD John Pagel Headshot John Pagel, MD, PhD person default Jacob D. Soumerai, MD Released: July 2, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue